Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

被引：0

作者：

Reboursiere, Emilie ^{[1
]}

Le Bras, Fabien ^{[2
]}

Morschhauser, Franck ^{[3
]}

Gyan, Emmanuel ^{[4
]}

Clavert, Aline ^{[5
]}

Malak, Sandra ^{[6
]}

Sibon, David ^{[7
]}

Damge, Marion ^{[8
]}

Gardin, Claude ^{[9
]}

Fornecker, Luc-Matthieu ^{[10
]}

Garidi, Reda ^{[11
]}

Tricot, Sabine ^{[12
]}

Houot, Roch ^{[13
]}

Joly, Bertrand ^{[14
]}

Abarah, Wajed ^{[15
]}

Choufi, Bachra ^{[16
]}

Pham, Anne-dominique ^{[1
]}

Chantepie, Sylvain P. ^{[17
]}

Fruchart, Christophe ^{[1
]}

Gac, Anne-Claire ^{[1
]}

Ollivier, Catherine ^{[1
]}

Marin, Emilie ^{[1
]}

Safar, Violaine ^{[18
]}

Parcelier, Anne ^{[19
,20
]}

Maisonneuve, Herve ^{[21
]}

Bachy, Emmanuel ^{[22
]}

Cartron, Guillaume ^{[23
]}

Jaccard, Arnaud ^{[24
]}

Tournilhac, Olivier ^{[25
]}

Rossi, Cedric ^{[26
]}

Perrot, Aurore ^{[27
]}

Martignoles, Jean-Alain ^{[28
]}

Tilly, Herve ^{[29
]}

Damaj, Gandhi ^{[30
]}

机构：

[1] CHU Caen, F-14000 Caen 5, France

[2] APHM, Bobigny, France

[3] Univ Lille 2, Ctr Hosp Univ, Hematol, Lille, France

[4] CHU Tours, UMR CNRS 7292, Serv Hematol & Therapie Cellulaire, Tours, France

[5] CHU Angers, Hematol, Angers, France

[6] CHU Curie, Paris, France

[7] APHP Necker, Paris 15, France

[8] Inst J Paoli I Calmettes, F-13009 Marseille, France

[9] Hop Avicenne, Hematol, F-93009 Bobigny, France

[10] CHU Strasbourg, F-67000 Strasbourg, France

[11] Hosp St Quentin, St Quentin en Yvelines, France

[12] CHU, Valenciennes, France

[13] Stanford Univ, Stanford, CA 94305 USA

[14] Ctr Hosp Sud Francilien, Dept Hematol, Corbeil Essonnes, France

[15] Hosp Meaux, Meaux, France

[16] Hop Boulogne Sur Mer, Boulogne, France

[17] Caen Univ Hosp, Dept Haematol, Caen, France

[18] Hosp Civils Lyon, Dept Hematol, Pierre Benite, France

[19] Ctr Hosp Univ, Hematol, Amiens, France

[20] Chu Amiens, Salouel, France

[21] CH, Dept Hematol & Oncol, La Roche Sur Yon, France

[22] Hosp Lyon, Lyon, France

[23] CHR Univ Tours, Montpellier, France

[24] CHU Limoges, Dept Hematol, Ctr Natl Reference Malad Rares Amylose AL & Autre, Limoges, France

[25] CHU Clermont Ferrand, Clermont Ferrand 1, France

[26] CHU, Dijon, France

[27] CHU, Vandoeuvre Les Nancy, France

[28] St Etienne Univ Hosp, St Etienne, France

[29] Ctr Henri Becquerel, Serv Hematol Clin, F-76038 Rouen, France

[30] CHU Caen, Dept Hematol, F-14000 Caen, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study
Reboursiere, Emilie
Le Bras, Fabien
Herbaux, Charles
Gyan, Emmanuel
Clavert, Aline
Morschhauser, Franck
Malak, Sandra
Sibon, David
Broussais, Florence
Braun, Thorsten
Fornecker, Luc-Matthieu
Garidi, Reda
Tricot, Sabine
Houot, Roch
Joly, Bertrand
Abarah, Wajed
Choufi, Bachra
Pham, Anne-Dominique
Gac, Anne-Claire
Fruchart, Christophe
Marin, Emilie
Safar, Violaine
Parcelier, Anne
Maisonneuve, Herve
Bachy, Emmanuel
Cartron, Guillaume
Jaccard, Arnaud
Tournilhac, Olivier
Rossi, Cedric
Schirmer, Luciane
Martignoles, Jean-Alain
Gaulard, Philippe
Tilly, Herve
Damaj, Gandhi
ONCOTARGET, 2016, 7 (51): : 85573 - 85583
[2] Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study
Bouabdallah, Krimo
Aubrais, Raphaelle
Chartier, Loic
Herbaux, Charles
Banos, Anne
Brice, Pauline
Ochmann, Marlene
Sibon, David
De Colella, Jean Marc Schiano
Cluzeau, Thomas
Laribi, Kamel
Le Calloch, Ronan
Bellal, Mathieu
Daguindau, Nicolas
Amorim, Sandy
Agbetiafa, Kossi
Chauchet, Adrien
Hammami, Marwa
Durot, Eric
Bonnet, Christophe
Robles, Margot
Fouillet, Ludovic
Bijou, Fontanet
Tournilhac, Olivier
Gaulard, Philippe
Parrens, Marie
Milpied, Noel-Jean
Damaj, Gandhi Laurent
BLOOD, 2021, 138
[3] Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study
Bhurani, Mansi
Admojo, Lorenz
Van der Weyden, Carrie
Twigger, Robert
Bazargan, Ali
Quach, Hang
Zimet, Allan
Coyle, Luke
Lindsay, Julian
Radeski, Dejan
Hawkes, Eliza
Kennedy, Glen
Irving, Ian
Gutta, Naadir
Trotman, Judith
Yeung, James
Dunlop, Lindsay
Hua, Minh
Giri, Pratyush
Yuen, Sam
Panicker, Shyam
Moreton, Susan
Khoo, Liane
Scott, Ashleigh
Kipp, David
McQuillan, Andrew
McCormack, Chris
Dickinson, Michael
Prince, Henry Miles
LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 330 - 336
[4] Multicenter, phase II study of bendamustine in refractory or relapsed T-cell lymphoma: The BENTLY trial.
Gressin, Remy
Damaj, Gandhi Laurent
Bouabdallah, Kamal
Cartron, Guillaume
Choufi, B.
Gyan, Emmanuel
Jaccard, Arnaud
Park, Sophie
De Colella, Jean-Marc Schiano
Voillat, Laurent
Joly, Bertrand
Le Gouill, Steven
Saad, Alain
Sanhes, Laurence
Moles-Moreau, Marie-Pierre
Bubenheim, Michael
Bene, Marie C.
Martin, Antoine
Marolleau, Jean Pierre
Lamy, Thierry
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[5] A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas
Cheson, Bruce D.
Crawford, Jeanette
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) : 528 - 533
[6] Bendamustine in Combination with Gemcitabine and Vinorelbine As Salvage Regimen for Relapsed or Refractory Peripheral T-Cell Lymphomas: A Retrospective Single Center Experience
Bagnoli, Filippo
De Feo, Jacopo Calabrese
Ricci, Francesca Livia Letizia
Mariotti, Jacopo
Sarina, Barbara
Balzarotti, Monica
Taurino, Daniela
Mannina, Daniele
De Philippis, Chiara
Rahal, Daoud
Bonometti, Arturo
Magagnoli, Massimo
Mazza, Rita
Rodari, Marcello
Giordano, Laura
Bramanti, Stefania
Carlo-Stella, Carmelo
Santoro, Armando
BLOOD, 2024, 144 : 1681 - 1682
[7] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
Jung Yong Hong
Dok Hyun Yoon
Cheolwon Suh
Won Seog Kim
Seok Jin Kim
Jae-Cheol Jo
Jin Seok Kim
Won-Sik Lee
Sung Yong Oh
Yong Park
Sung-Yong Kim
Mark Hong Lee
Ho Sup Lee
Young Rok Do
Annals of Hematology, 2018, 97 : 1437 - 1443
[8] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
Hong, Jung Yong
Yoon, Dok Hyun
Suh, Cheolwon
Kim, Won Seog
Kim, Seok Jin
Jo, Jae-Cheol
Kim, Jin Seok
Lee, Won-Sik
Oh, Sung Yong
Park, Yong
Kim, Sung-Yong
Lee, Mark Hong
Lee, Ho Sup
Do, Young Rok
ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1437 - 1443
[9] Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience
A. García-Noblejas
C. Martínez Chamorro
B. Navarro Matilla
C. Da Silva Rodriguez
T. J. González-Lopez
R. Oña Navarrete
M. J. Ramírez Sánchez
P. Martínez Barranco
J. J. Sánchez Blanco
C. Nicolás
R. Pérez
B. Sánchez González
A. M. Ruedas López
E. Domingo-Domenech
C. Panizo
S. Macia
E. Fernández-Fonseca
J. Cannata-Ortiz
R. Arranz
Annals of Hematology, 2014, 93 : 1551 - 1558
[10] Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience
Garcia-Noblejas, A.
Martinez Chamorro, C.
Navarro Matilla, B.
Da Silva Rodriguez, C.
Gonzalez-Lopez, T. J.
Ona Navarrete, R.
Ramirez Sanchez, M. J.
Martinez Barranco, P.
Sanchez Blanco, J. J.
Nicolas, C.
Perez, R.
Sanchez Gonzalez, B.
Ruedas Lopez, A. M.
Domingo-Domenech, E.
Panizo, C.
Macia, S.
Fernandez-Fonseca, E.
Cannata-Ortiz, J.
Arranz, R.
ANNALS OF HEMATOLOGY, 2014, 93 (09) : 1551 - 1558

← 1 2 3 4 5 →